Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit
30 March 2023 - 7:00AM
Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:
DRTS, DRTSW), the developer of the innovative alpha-radiation
cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief
Financial Officer, will present in-person at the Jefferies
Radiopharma Innovation Summit in New York City on Monday, April
3rd, 2023.
Event: |
Jefferies Radiopharma Innovation Summit |
Date: |
Monday, April 3rd, 2023 |
Time: |
3:30-4:00 PM ET |
Location: |
Jefferies, NY, New York |
Raphi Levy will also be available for 1x1 investor meetings at
the conference. Please reach out to your Jefferies representative
to schedule.
About Alpha Tau Medical, Ltd.Founded in 2016,
Alpha Tau is an Israeli medical device company that focuses on
research, development, and potential commercialization of the Alpha
DaRT for the treatment of solid tumors. The technology was
initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari
from Tel Aviv University.
Investor Relations Contact:IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jul 2023 to Jul 2024